Download - Initiating the Right Interstitial Lung Disease Treatment Approach

Discover

Podcast Features
Your all-in-one podcasting solution.

Blog to Podcast
Turn your blog into an engaging podcast.
Livestream
High-performing audio live, without limits.

Podcast Studio
Easy-to-use audio recorder app.
Podbean AI
AI-Enhanced Audio Quality and Content Generation.

Podcast App
The best podcast player & podcast app.

Ads Marketplace
Join Ads Marketplace to earn money
through sponsorship on your podcast.

PodAds
Manage your ads with dynamic ad insertion capability.
Apple Podcasts Subscriptions Integration
Effortlessly publish and manage exclusive episodes for your
Apple Podcasts subscribers directly from Podbean.
Live Streaming
Receive livestream rewards from your audience and earn
recurring income from your Fan Club membership.

All Arts Business Comedy Education
Fiction Government Health & Fitness History Kids & Family
Leisure Music News Religion & Spirituality Science
Society & Culture Sports Technology True Crime TV & Film
Live

How to Start a Podcast
How to Start a Live Podcast
How to Monetize a podcast
How to Promote Your Podcast
How to Use Group Recording

Log in
Start your podcast for free

Podcasting
Monetization
Advertisers
Enterprise
Pricing
Discover

Conference Coverage

Science & Medicine

Initiating the Right Interstitial Lung Disease Treatment Approach

2019-11-15

Download Right click and do "save link as"

Host: Anoop Nambiar, MD
Guest: Joshua Mooney, MD, MS

At the 2019 CHEST annual conference, Dr. Anoop Nambiar got a chance to catch up with Dr. Joshua Mooney, who highlighted the conference’s key takeaways on interstitial lung disease, like recently developed screening tools, lung transplant technologies, self-care strategies for patients, and more.

Along with strategies and the latest treatment approaches, Drs. Nambiar and Mooney will discuss clinically relevant suggestions that healthcare providers can start to use today in patients with ILD.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.